Video Experimental Relacionado

Updated: Jun 17, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

9.4K

CD48 es un nuevo punto de control inmune en los macrófagos asociados al tumor en el carcinoma hepatocelular

Gege Shi1, Yang Xiao1,2, Zhaozhao Li1

  • 1State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Biotechnology Center, School of Pharmacy, Fourth Military Medical University, Xi'an, Shaanxi, China.

Gut
|January 2, 2026
PubMed
Resumen

No abstract available in PubMed .

Palabras clave:
Carcinoma hepatocelularRespuesta inmunológicaMecanismos moleculares

Más Videos Relacionados

In Vitro Assay to Study Tumor-macrophage Interaction08:36

In Vitro Assay to Study Tumor-macrophage Interaction

Published on: August 1, 2019

8.0K
Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma08:25

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Published on: April 25, 2025

653

Videos de Conceptos Relacionados

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.